Alfayez, Alsaqoub, Qattan, Alghamdi, Elfeky, Alrowaie, Aljasser and Syed:

Peritoneal dialysis related infections in a tertiary care hospital in Riyadh, Saudi Arabia

Somia M. Alfayez, MBBS, Shahd M. Alsaqoub, MBBS, Abeer Y. Qattan, MBBS, Mada A. Alghamdi, MBBS, Dalia S. Elfeky, MD, PhD, Fadel A. Alrowaie, MD, Doaa S. Aljasser, BHSc, Sadiqa B. Syed, MD, PhD

From the College of Medicine (Alfayez, Alsaqoub, Qattan, Alghamdi, Elfeky, Syed), Princess Nourah Bint Abdulrahman University, from the Department of Nephrology (Alrowaie), King Fahad Medical City, from the Health Sciences Research Center (Aljasser), Princess Nourah Bint Abdulrahman University, Riyadh, Kingdom of Saudi Arabia; from the Department of Microbiology and Immunology (Elfeky), Faculty of Medicine, Cairo University, Giza, Egypt

Received 14th November 2018. Accepted 1st January 2019.

Address correspondence and reprint request to: Dr. Shahd M. Alsaqoub, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Kingdom of Saudi Arabia. E-mail: shahd.sq@gmail.com ORCID ID: https://orcid.org/0000-0002-6662-5535


ABSTRACT

Objectives: To detect the incidence of and risk factors for infections among patients with end-stage renal disease (ESRD) undergoing peritoneal dialysis (PD).

Methods: A retrospective cohort study was conducted at the PD unit of King Fahad Medical City. End-stage renal disease patients above the age of 12 years who were undergoing PD management between January 2006 and March 2016 were included.

Results: One hundred PD patients were enrolled in the study and examined over a total observation period of 2,553 patient-months. The leading ESRD etiology was hypertension (26.3%). The mean duration of PD was 28.05 months. A total of 45 patients developed 101 episodes of technique-related infections (TRIs). Peritonitis represented the majority of these episodes (90 episodes), with an overall rate of one episode per 28.3 patient-months. TRIs were mostly caused by coagulase-negative staphylococci. A total of 12 patients developed non-technique related infections (NTRIs). There was a statistically significant difference between patients with TRI and non-infected patients regarding the presence of diabetes and duration of dialysis. No peritonitis-related deaths were noted. In total, 21 patients continued on PD and 18 patients were shifted to hemodialysis (HD).

Conclusion: In our setting, ESRD patients undergoing PD are more susceptible to TRIs than NTRIs. Diabetes increases the risk of developing TRIs. The high incidence of coagulase-negative staphylococcal TRI suggests touch contamination.

Saudi Med J 2019; Vol. 40 (2): 147-151
doi: 10.15537/smj.2019.2.23898

End-stage renal disease (ESRD) is defined as an irreversible decline in kidney function that requires renal replacement therapy (RRT) for survival.1 It is a major healthcare problem; the prevalence and global incidence of cases with high costs and poor outcomes are increasing.2 According to a meta-analysis, the leading cause of ESRD in Gulf countries is diabetic nephropathy (17%), followed by glomerulonephritis (13%) and hypertensive nephropathy (8%), and the prevalence of diabetic nephropathy has significantly increased over time.3 The RRT required by patients with ESRD involves dialysis or a kidney transplant.

The introduction of continuous ambulatory peritoneal dialysis (CAPD) in 1976 led to an increase in the international use of peritoneal dialysis (PD).4 PD may be recommended over hemodialysis (HD) for younger patients and adults with no serious comorbidities.5 In 2015, the Saudi Center for Organ Transplantation (SCOT) reported that 16,897 patients underwent dialysis in Saudi Arabia. A total of 1,307 patients underwent PD. Of these, 68% received continuous cycler peritoneal dialysis (CCPD), 27% received CAPD and 5% received intermittent peritoneal dialysis (IPD).6 Dialysis effectively relieves the signs and symptoms of uremia and fluid overload, but it is a chronic therapy that is associated with discomfort, inconvenience, and some complications for the patient.7 Infectious complications among patients undergoing dialysis are a major cause of morbidity and hospitalization, and they are the most common cause of death among these patients after cardiovascular causes.8 The main technique-related infections (TRIs) that occur during PD include peritonitis, exit-site infection (ESI), and tunnel infection. In addition, peritonitis is a major complication of PD, resulting in around 18% of the infection-related mortality among PD patients.9 Even though less than 4% of peritonitis episodes lead to death, this complication is still a risk for mortality.9,10 It can also cause peritoneal membrane damage, which is the main cause of technique failure and why patients switch to HD. A 5-year single-center study that was carried out in Riyadh11 reported the peritonitis rate as one episode per 24.51 patient-months, while the ESI rate was one episode per 56.21 patient-months. Non-technique related infections (NTRIs) associated with PD, such as pneumonia, are not as common as in HD patients.12

The current study was conducted to determine the incidence of PD-related infections at a tertiary care hospital in Riyadh and to assess the possible risk factors associated with these infections.

Methods

The study was approved by the Institutional Review Board (IRB) of the College of Medicine at Princess Nourah bint Abdulrahman University (PNU) as well as the IRB of King Fahad Medical City (KFMC). It is a retrospective cohort study that was conducted within the dialysis unit at KFMC, Riyadh, Saudi Arabia. All ESRD patients above the age of 12 years who underwent PD (APD and CAPD) between January 2006 and March 2016 were included. In addition patients who did dialysis by themselves or required a helper were included. No exclusion criteria were applied. The medical records of the in- and outpatients included in the study were reviewed. A data sheet was used to collect information from the records, including patients’ demographics, body mass index (BMI), smoking status, ESRD etiology, Charlson Comorbidity Index (CCI) score,13 initial dialysis modality, dialysis vintage (duration of dialysis), type of PD, incidence of TRI, and NTRI. For patients with peritonitis, additional information was collected, including the causative organism and outcome of each episode. Prior studies were identified by searching Pubmed and Google Scholar. Some of the keywords used were “peritoneal dialysis” and “peritonitis”.

All patients had Tenckhoff indwelling silicone double-cuff catheters, which were surgically placed after administration of a prophylactic antibiotic. A full PD prescription was started two weeks after catheter insertion. All patients and caregivers received condensed three-day training at the Baxter and Fresenius PD training centers in Riyadh. The patients were followed in the outpatient clinic every 4-8 weeks and were asked to inform the hospital if the PD fluid became turbid or if they experienced abdominal pain, vomiting, or diarrhea.

All PD patients suspected to have an infection were evaluated by a nephrologist. Peritoneal dialysis-associated peritonitis was defined as inflammation of the peritoneal membrane in a patient receiving PD with abdominal pain, vomiting, fever, and cloudy fluid. A diagnosis was confirmed by obtaining an effluent cell count, differential, and culture (White blood cells WBC >100 cells/ml, 50% polymorphonuclear leukocytes in PD fluid, or a positive culture).9 Exit-site infection was defined as the presence of purulent discharge with or without erythema of the skin at the catheter–epidermal interface.9 Tunnel infection was suspected when erythema, edema, or tenderness over the subcutaneous pathway were observed.9 Non-technique related infections indicate that the patient may have pneumonia, a urinary tract infection (UTI), or a soft tissue infection.

Statistical analysis Descriptive statistics (means and standard deviations) were used to describe the studied sample. Quantitative data were analyzed by a t-test and qualitative variables were associated by a Chi-square test. P-values less than 0.05 were considered to be statistically significant. All statistical analyses were conducted using the Statisitcal Package for Social Sciences Version 23 (Armonk, NY: IBM Corp.).

Results

The medical records of 100 patients were reviewed. The proportions of patients who were male and female were almost equal (53% and 47%). The mean age was 40.7±19.3 years. The mean BMI was 23.9±5.7 kg/m2. A total of 32 patients (32%) were diabetic. The mean CCI was 3.4±1.9. The leading ESRD etiology was hypertension (26.3%), followed by an unknown etiology (23.7%), glomerulonephritis (23%), diabetic nephropathy (22%), polycystic kidney (2%), obstructive uropathy (2%), and reflux (1%). The mean duration for which patients received PD was 28.05±24.4 months.

A total of 45 patients developed a TRI, such as peritonitis, ESI, and tunnel infection. In total, 101 episodes were reported, most of which involved peritonitis (90 episodes). Of the 45 patients, 35 developed only peritonitis, 3 developed an ESI, 1 patient developed a tunnel infection, 5 developed peritonitis and an ESI, one patient had both infections in the same episode, while 4 patients had each infection in a different episode, and one patient had peritonitis and tunnel infection in the same episode. Only 12 patients developed an NTRI, usually pneumonia or a UTI.

Table 1 shows the baseline characteristics of the patients who developed a TRI. It shows that no statistically significant difference was found between patients with and without TRIs in terms of age, gender, or BMI, while a statistically significant difference was found in terms of CCI, dialysis vintage, and diabetes. Patients who had TRIs had more comorbidities and longer dialysis vintage, while patients with diabetes were more likely to develop TRIs (62.5%) than non-diabetics (36.8%). No relationships or differences were observed for the variables associated with the 12 patients with NTRIs (Table 2).

Table 1 - Relation between baseline characteristics and the occurrence of technique-related infections.

thumblarge

Table 2 - Relation between baseline characteristics and the occurrence of non-technique related infections.

thumblarge

A total of 15 patients (36.6%) had one episode of peritonitis, 10 (24.4%) had 2 episodes, 6 (14.6%) had 3 episodes, 3 (7.3%) had 4 episodes, 2 (4.9%) had 5 episodes, and 2 (4.9%) had 6 episodes. While the number of episodes for 3 patients (7.3%) was unknown. The Pearson correlation coefficient was used to analyze the correlation between age, BMI, CCI, and dialysis vintage and the number of episodes. No correlation was observed, as shown in Table 3.

Table 3 - Pearson correlation coefficient of the number of episodes with different variables.

thumblarge

Technique-related infections were mostly caused by coagulase-negative staphylococci (23% of the episodes), followed by culture-negative (22%). Most peritonitis episodes were also caused by coagulase-negative staphylococci (24.4%). One patient was diagnosed with TB peritonitis based on a CT scan. The causative organisms of peritonitis over a 10-year period are shown in Table 4. Of the 90 peritonitis episodes, the patient continued on PD in 65 episodes, while 18 episodes ended with the patient shifting to HD. The outcome of 7 episodes was unknown. Although a higher percentage of episodes caused by gram negative organisms ended with catheter removal than those caused by gram positive organisms (46.7% versus 21.6%), the difference was not statistically significant. Out of the 41 patients who developed peritonitis, 21 patients continued on PD and 18 patients were shifted to HD. The outcome of 2 patients was unknown. No peritonitis-related deaths were noted.

Table 4 - Causative organisms of peritonitis among peritoneal dialysis patients over a 10-year period.

thumblarge

Discussion

This retrospective cohort study reported the incidence of PD-related infections in a tertiary care hospital in Riyadh and assessed the possible risk factors associated with these infections. Of the 100 patients enrolled in the study, there was no major difference in the proportions of males and females. The mean age was 40.7±19.3, which was younger than the mean age reported in another study (53.8±17.52).14 Hypertension was the most common cause of ESRD (26.3%), followed by unknown etiology (23.7%). This finding was inconsistent with a study conducted in Riyadh, which reported that diabetic nephropathy was the leading cause of ESRD (23.6%), followed by nephrosclerosis and an unknown etiology (20%).15

A total of 45 patients developed TRIs. Peritonitis represented the majority of these infections, with one episode occurring per 28.3 patient-months. This rate is lower than the rate reported in an earlier study conducted at King Khalid University Hospital in Riyadh over a period of 5 years (one episode per 24.51 patient-months).11 It is also lower than the rate reported in a study conducted at the Security Forces Hospital Program in Riyadh (one episode per 21 patient-months).15 A higher rate was reported in Sudan (one episode per 13.9 patient-months).16 Lower rates were reported in North India (one episode per 30.6 patient-months)17 and in the US (one episode per 32.7 patient-months), while Canada had a comparable rate (one episode per 27.6 patient-months).18 In this study, patients with TRIs had a mean CCI score of 4.02. In the current study, there was no relationship between gender and the incidence of TRI. However, a previous study found that females were at greater risk of developing peritonitis.19 The current study also found no significant association between age and BMI and increased risk of TRI. However, other studies showed that older age was a risk factor for peritonitis.19,20 Two prior studies reported different results regarding BMI; one found that obesity is a risk factor for peritonitis when patients start PD,21 while the other found no association between obesity and the risk of developing peritonitis.22

The current study found that diabetic patients have a higher risk of developing TRIs (62.5%) compared to non-diabetics (36.8%), similar to the results of another study.20 However, diabetes, as a risk factor for infections, does not exclude the benefits of PD for diabetic patients.23 Further, this study found no correlation between age, BMI, CCI, and dialysis vintage and the number of peritonitis episodes. In a review article, there were contradicting results regarding gender, age, BMI and comorbidities as risk factors for peritonitis, however diabetes was an established risk for peritonitis.24

Although this topic was not discussed in the current study, some studies showed that there is a relationship between the type of organism and the risk of developing multiple episodes of peritonitis.25,26 In the current study, TRIs were mostly caused by coagulase-negative staphylococci (23% of episodes), followed by culture negative (22%). This is consistent with a study carried out in Riyadh that reported staphylococcus (epidermidis and aureus) was the most common organism leading to infection (24% of cases).15 Similar results were reported in Korea; most peritonitis cases were caused by coagulase-negative staphylococci (39.9%) and culture negative (36.9%).27 No peritonitis-related deaths were reported in the current study.

The duration of PD was longer for patients who had infections (mean = 34.5 months). Twenty-one patients continued to receive PD after developing peritonitis, and 18 patients shifted to HD. Another study with 72 patients conducted in Riyadh reported that 35 patients continued to receive PD, and 13 patients shifted to HD.11

Our study was limited by being a single center study. A multi-center study with a larger sample size is recommended.

In conclusion, this study found that patients receiving PD are more susceptible to TRIs than to NTRIs. In addition, it found that diabetes increases the risk that patients undergoing PD will develop TRIs. The high incidence of coagulase-negative staphylococcal TRIs suggests touch contamination. Further, controlling diabetes is important for decreasing the incidence of TRIs. It is recommended that healthcare professionals educate and train patients and families about PD infection control procedures.

Acknowledgment

We acknowledge that this project was supported by the Health Science Research Center at Princess Nourah bint Abdularhman, Riyadh, Saudi Arabia. We would also like to thank (www.scribendi.com) for English language editing.

References

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification and stratification. Am J Kidney Dis 2002;39 (1_Suppl):1-266.

2. Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J et al. Definition and classification of chronic kidney disease:A position statement from Kidney Disease:Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-2100. CrossRef

3. Hassanien A, Al-Shaikh F, Vamos E, Yadegarfar G, Majeed A. Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council:a systematic review. JRSM Short Rep 2012;3:38-38. CrossRef

4. Gilbert S, Weiner D, Bomback A, Perazella M, Tonelli M. National Kidney Foundation's Primer on Kidney Diseases. 6th ed. Boston:Saunders;2013. p. 521. https://medicinahmx.files.wordpress.com/2017/07/national-kidney-foundations-primer-on-kidney-diseases.pdf

5. Bieber S, Mehrotra R. Patient and technique survival of older adults with ESRD treated with peritoneal dialysis. Perit Dial Int 2015;35:612-617. CrossRef

6. Saudi Center for Organ Transplantation. Annual Report 2015. Report number 8. 2015. Available:http://www.scot.gov.sa/images/Annual_Report_2015_En_4.pdf

7. Bleyer A. Indications for initiation of dialysis in chronic kidney disease [Internet]. Uptodate.com. 2015 [cited 5 December 2015] Available:http://www.uptodate.com/contents/indications-for-initiation-of-dialysis-in-chronic-kidney-disease

8. Saran R, Li Y, Robinson B, et al. US Renal Data System 2015 Annual Data Report:Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2016;67 (3 Suppl 1):S1-S434. CrossRef

9. Li P, Szeto C, Piraino B, Bernardini J, Figueiredo A, Gupta A et al. Peritoneal Dialysis-Related Infections Recommendations:2010 Update. Perit Dial Int 2010;30:393-423. CrossRef

10. Fried L, Bernardini J, Johnston J, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. Clin J Am Soc Nephrol 1996;7:2176-2182. PubMed

11. Alwakeel J, Alsuwaida A, Askar A, Memon N, Usama S, Alghonaim M, et al. Outcome and complications in peritoneal dialysis patients:A five-year single center experience. Saudi J Kidney Dis Transpl 2011;22:245-251. PubMed

12. van Diepen A, Hoekstra T, Rotmans J, de Boer M, le Cessie S, Suttorp M et al. The association between dialysis modality and the risk for dialysis technique and non-dialysis technique-related infections. Nephrol Dial Transplant 2014;29:2244-2250. CrossRef

13. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies:Development and validation. J Chronic Dis 1987;40:373-383. CrossRef

14. Al Wakeel J, Mitwalli A, Al Mohaya S, Abu-Aisha H, Tarif N, Malik G et al. Morbidity and Mortality in ESRD Patients on Dialysis. Saudi J Kidney Dis Transpl 2002;13:473-477. PubMed

15. Malik G, Al-Harbi A, Al-Mohaya S, Al-Awaishe R, Kechrid M, Zohair A et al. Chronic Peritoneal Dialysis. A single-center experience. Perit Dial Int 2003;23:188-191. PubMed

16. Elhassan E, Kaballo B, Fedail H, Abdelraheem M, Ali T, Medani S, et al. Peritoneal dialysis in the Sudan. Perit Dial Int 2007;27:503-510. PubMed

17. Vikrant S. Long-term clinical outcomes of peritoneal dialysis patients:9-year experience of a single center from North India. Perit Dial Int 2014;34:426-433. CrossRef

18. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int 2006;70:S55-S62. CrossRef

19. Kotsanas D, Polklnghorne K, Korman T, Atkins R, Brown F. Risk factors for peritoneal dialysis-related peritonitis:Can we reduce the incidence and improve patient selection?. Nephrology 2007;12:239-245. CrossRef

20. Tsai C, Lee J, Liu T, Ko W, Wu C, Pan C et al. Effects of age and diabetes mellitus on clinical outcomes in patients with peritoneal dialysis-related peritonitis. Surg Infect 2013;14:540-546. CrossRef

21. McDonald S, Collins J, Rumpsfeld M, Johnson D. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int 2004;24:340-346. PubMed

22. Nessim S, Komenda P, Rigatto C, Verrelli M, Sood M. frequency and microbiology of peritonitis and exit-site infection among obese peritoneal dialysis patients. Perit Dial Int 2013;33:167-174. PMC Free Article

23. Kuriyama S. Peritoneal dialysis in patients with diabetes:Are the benefits greater than the disadvantages?. Perit Dial Int 2007;27:S190-S195. PubMed

24. Kerschbaum J, König P, Rudnicki M. Risk factors associated with peritoneal-dialysis-related peritonitis. Int J Nephrol 2012;2012:1-11. PubMed

25. Stablein D, Nolph K, Lindblad A. Timing and characteristics of multiple peritonitis episodes:A report of the National CAPD Registry. Am J Kidney Dis 1989;14:44-49. CrossRef

26. Nessim S, Nisenbaum R, Bargman J, Jassal S. Microbiology of peritonitis in peritoneal dialysis patients with multiple episodes. Perit Dial Int 2012;32:316-321. CrossRef

27. Kim D, Yoo T, Ryu D, Xu Z, Kim H, Choi K et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis:A single center's experience over one decade. Perit Dial Int 2004;24:424-432. PubMed

Disclosure. Authors have no conflict of interests, and the work was not supported or funded by any drug company.

Refbacks

  • There are currently no refbacks.




Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.